Dallara Que 4
4 · MiniMed Group, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
MiniMed (MMED) CEO Dallara Que Receives 621,563 RSUs
What Happened Dallara Que, CEO of MiniMed Group, Inc. (MMED), was granted a total of 621,563 restricted stock units (RSUs) on 2026-03-11. These grants were not purchases or sales but conversion awards (transaction code A) — Medtronic RSUs held by the reporting person were converted into MMED RSUs as part of MMED’s separation from Medtronic. The filing shows no per-share cash price (N/A) because these are conversion awards, not an open-market trade.
Key Details
- Transaction date: 2026-03-11 (Form 4 filed 2026-03-13 — appears timely).
- Total RSUs granted: 621,563 (six tranches).
- Tranche breakdown and vesting (per filing footnotes):
- 281,937 RSUs — vest April 30, 2027.
- 127,609 RSUs — vest April 28, 2028.
- 57,239 RSUs — vest July 31, 2026.
- 80,842 RSUs — vest July 29, 2027.
- 51,044 RSUs — vest July 28, 2028.
- 22,892 RSUs — vest in two equal installments on March 10, 2026 and March 10, 2027.
- Price/value: N/A on the Form 4 lines; conversion amounts were determined using average Medtronic and MMED closing prices per the Employee Matters Agreement (see footnotes).
- Ownership after transaction: not specified in the excerpt provided.
- Notable footnotes: (F1–F2) awards were converted under the Employee Matters Agreement and an Equity Award Conversion using specified average closing prices; (F3–F9) describe plan (2026 LTIP) and vesting schedules for each tranche.
Context
- These were conversion grants arising from MMED’s separation from Medtronic, not new cash purchases or sales. Converted RSUs are time-vesting equity awards that will convert to shares on their respective vesting dates.
- Because this is an award/conversion (not a sale), it does not directly signal buying or selling sentiment; it reflects the transfer and re-denomination of prior Medtronic awards into MMED equity per separation agreements.
- No 10b5-1 plan, tax withholding, or late-filing flags were indicated in the provided excerpt.
Insider Transaction Report
Form 4
Dallara Que
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1][F2][F3][F4]2026-03-11+281,937→ 281,937 total - Award
Common Stock
[F1][F2][F5][F4]2026-03-11+127,609→ 127,609 total - Award
Common Stock
[F1][F2][F6][F4]2026-03-11+57,239→ 57,239 total - Award
Common Stock
[F1][F2][F7][F4]2026-03-11+80,842→ 80,842 total - Award
Common Stock
[F1][F2][F8][F4]2026-03-11+51,044→ 51,044 total - Award
Common Stock
[F1][F2][F9][F4]2026-03-11+22,892→ 22,892 total
Footnotes (9)
- [F1]In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").
- [F2]Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").
- [F3]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027.
- [F4]Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- [F5]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028.
- [F6]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026.
- [F7]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027.
- [F8]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028.
- [F9]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027.
Signature
/s/ Bryan F. Kelly, attorney-in-fact|2026-03-13